{"title":"Blood Cancer","description":null,"products":[{"product_id":"brutini-140-ibrutinib","title":"Brutini 140 (Ibrutinib)","description":"\u003cp\u003e\u003cstrong\u003eBrutini 140\u003c\/strong\u003e contains \u003cstrong\u003eIbrutinib 140 mg\u003c\/strong\u003e, a targeted anticancer medicine belonging to the Bruton’s tyrosine kinase (BTK) inhibitor class. It is used in the treatment of certain blood cancers, including \u003cstrong\u003echronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and mantle cell lymphoma (MCL)\u003c\/strong\u003e. Brutini 140 works by blocking BTK, a protein involved in the growth and survival of certain cancer cells. It should be used only under the supervision of a qualified healthcare professional.\u003c\/p\u003e","brand":"XOMEDS","offers":[{"title":"Default Title","offer_id":44894149410859,"sku":null,"price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/brutini-140-142.jpg?v=1787256957"},{"product_id":"enacitib-50-enasidenib","title":"Enacitib 50 (Enasidenib)","description":"\u003cp\u003e\u003cstrong\u003eEnacitib 50\u003c\/strong\u003e contains \u003cstrong\u003eEnasidenib 50 mg\u003c\/strong\u003e, a targeted anti-cancer medicine used in the treatment of certain types of \u003cstrong\u003eacute myeloid leukemia (AML)\u003c\/strong\u003e associated with specific IDH2 mutations. It works by inhibiting the abnormal IDH2 enzyme and may help slow the growth of cancer cells. Enacitib 50 is a prescription medicine and should be used under the supervision of a qualified healthcare professional. Ziska Pharma lists it as an \u003cstrong\u003eanti-cancer product for export only\u003c\/strong\u003e, with a pack size of \u003cstrong\u003e30’s\u003c\/strong\u003e.\u003c\/p\u003e","brand":"XOMEDS","offers":[{"title":"Default Title","offer_id":44894222909483,"sku":null,"price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/enacitib-50-151.jpg?v=1787258990"},{"product_id":"enacitib-100-enasidenib","title":"Enacitib 100 (Enasidenib)","description":"\u003cp\u003e\u003cstrong\u003eEnacitib 100\u003c\/strong\u003e contains \u003cstrong\u003eEnasidenib 100 mg\u003c\/strong\u003e, a targeted anti-cancer medicine used for certain patients with \u003cstrong\u003eacute myeloid leukemia (AML)\u003c\/strong\u003e associated with specific IDH2 mutations. It works by inhibiting the abnormal IDH2 enzyme, helping to control the growth of cancer cells. Enacitib 100 is a prescription medicine intended for use under medical supervision.\u003c\/p\u003e","brand":"XOMEDS","offers":[{"title":"Default Title","offer_id":44894233198635,"sku":null,"price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/enacitib-100-152.jpg?v=1787259396"},{"product_id":"ventax-100-venetoclax","title":"Ventax 100 (Venetoclax)","description":"\u003cp\u003e\u003cstrong\u003eVentax 100 (Venetoclax)\u003c\/strong\u003e\u003cspan\u003e is an oral targeted anti-cancer medicine containing \u003c\/span\u003e\u003cstrong\u003evenetoclax\u003c\/strong\u003e\u003cspan\u003e, a BCL-2 inhibitor that helps promote the death of cancer cells. It is used in the treatment of certain \u003c\/span\u003e\u003cstrong\u003eblood cancers\u003c\/strong\u003e\u003cspan\u003e, including chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML), depending on the treatment regimen. Ventax 100 contains \u003c\/span\u003e\u003cstrong\u003e100 mg of venetoclax\u003c\/strong\u003e\u003cspan\u003e and is supplied in a \u003c\/span\u003e\u003cstrong\u003e60-tablet pack\u003c\/strong\u003e\u003cspan\u003e. \u003c\/span\u003e\u003c\/p\u003e","brand":"XOMEDS","offers":[{"title":"Default Title","offer_id":44896629489707,"sku":null,"price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/ventax-100-169.jpg?v=1787306930"},{"product_id":"acatinib-acalabrutinib-inn","title":"ACATINIB (ACALABRUTINIB INN)","description":"\u003cp\u003e\u003cstrong\u003eACATINIB (Acalabrutinib INN)\u003c\/strong\u003e\u003cspan\u003e is an oral targeted anti-cancer medicine containing \u003c\/span\u003e\u003cstrong\u003eacalabrutinib\u003c\/strong\u003e\u003cspan\u003e, a selective Bruton’s tyrosine kinase (BTK) inhibitor that blocks signaling involved in the growth and survival of abnormal B cells. It is primarily used for certain \u003c\/span\u003e\u003cstrong\u003eB-cell blood cancers\u003c\/strong\u003e\u003cspan\u003e, including chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), and in certain cases of mantle cell lymphoma. ACATINIB is supplied as \u003c\/span\u003e\u003cstrong\u003e100 mg capsules\u003c\/strong\u003e\u003cspan\u003e, with a \u003c\/span\u003e\u003cstrong\u003e60-capsule pack\u003c\/strong\u003e\u003cspan\u003e. \u003c\/span\u003e\u003c\/p\u003e","brand":"XOMEDS","offers":[{"title":"Default Title","offer_id":44896915128363,"sku":null,"price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/acatinib-323.png?v=1787313288"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/collections\/Frame_191_1.webp?v=1787048155","url":"https:\/\/xomeds.com\/collections\/blood-cancer.oembed","provider":"XOMEDS","version":"1.0","type":"link"}